The abundance of gut microbiota, the content of products generated by microbial biochemical reactions, and the content of bacterial enzymes are used as methods for detecting disease risk.

TWI946008BActive Publication Date: 2026-11-11SYNOMICS BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
TW114131395
Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-08-18
Publication Date
2026-11-11
Estimated Expiration
2045-08-17
Patent Text Reader

Abstract

This invention provides a method for detecting disease risk using the abundance of gut microbiota, the biochemical reactions of gut microbiota with increased activity, and the content of bacterial enzymes. The disease is Parkinson's disease. It can also simultaneously detect at least one of the following groups: bone loss, osteoporosis, sarcopenia, sleep disorders, depression, and Alzheimer's disease. By detecting the abundance of specific microorganisms, the biochemical reactions of gut microbiota with increased activity, and the content of specific bacterial enzymes, the accuracy of disease risk detection can be significantly improved, and the detection cost is relatively low. It can be widely used in disease risk management in the field of medical assistance.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A method for in vitro detection of disease risk, comprising detecting and analyzing the abundance of a microorganism, a gut microbiota biochemical reaction, and the content of a bacterial enzyme in a fecal sample. When the abundance of the microorganism, the gut microbiota biochemical reaction, and the bacterial enzyme content in the fecal sample are significantly higher than the corresponding indicators in a fecal sample from a healthy population, the fecal sample provider is determined to be at risk of the disease; the disease is Parkinson's Disease (PD); the microorganism includes: Megasphaera elsdenii, Phascolarctobacterium faecium, Acidaminococcus intestini, Dryocola boscaweniae, Dialistister massiliensis, Alistipes putredinis, and Desulfovibrio porci; The biochemical reactions of this intestinal bacteria include: dolicol and dolichyl phosphate biosynthesis and dimethyl sulfide degradation I; the bacterial enzymes include: dehydrodolichyl diphosphate synthase, polyprenol reductase, dolicol kinase, dissimilatory dimethyl-sulfide monooxygenase, and methanethiol oxidase.

2. The method for in vitro detection of disease risk as described in claim 1, which uses a long-fragment gene sequence to analyze the abundance of microorganisms in the gut, intestinal biochemical reactions, and the content of bacterial enzymes.

Citation Information

Patent Citations

  • Methods and materials for determining parkinson's disease or a risk thereof

    WO2021260276A1